Refine your search
Availability
-
Authors
-
Topics
- Aged, 80 and over
- Angiogenesis Inhibitors
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization
- Cohort Studies
- Cost-Benefit Analysis
- Drug Administration Schedule
- Drug Costs
- Health Care Costs
- Humans
- Macular Degeneration
- Markov Chains
- Models, Theoretical
- Quality-Adjusted Life Years
- Ranibizumab
- Vascular Endothelial Growth Factor A
- Visual Acuity
- Wet Macular Degeneration
- drug therapy
- Show more
- Show less
-
Languages